Fundraise

Yuequan Bionic raises hundreds of millions of yuan for bionic robotic hands

What's the deal? Chinese robotics startup Yuequan Bionic Technology has closed a Pre-A round worth several hundred million yuan. Changfa Fund, Huakong FundDealroom has a profile for this one. Try Dealroom →, China AMC, Guoli Minsheng, and Xingke Venture CapitalDealroom has a profile for this one. Try Dealroom → led the round, with existing backer Zhongguancun Qihang Investment following on.

What does it do? Yuequan builds dexterous robotic hands, motors, humanoid robots, and behaviour models in-house. Its technology stems from research by Ren Lei, a professor at the University of Manchester, that mimics how human bones, muscles, and ligaments work together.

The products: Its flagship Y-Hand M1, launched in early July 2026, weighs 299.7g, packs 26 degrees of freedom, and grips at up to 200N. A higher-end M2 offers 38 degrees of freedom, which the company calls the highest of any bionic dexterous hand.

Where the money goes: Funds will support hiring, product research, and production capacity. The company is building a manufacturing base in Beijing's Changping district.

Yuequan says it has secured over US$13.8M in cumulative orders across smart manufacturing, warehousing, inspection, healthcare, and domestic services.

Why now? Humanoid robots are moving past the prototype stage toward commercial rollout, with dexterous hands a key focus for investors. Chinese dexterous-hand companies raised nearly US$687.5M in the first quarter of 2026 alone, according to the source.

What could go wrong? The sector risks a race to stack hardware specs like degrees of freedom and torque. Rigid designs struggle to balance precision, load capacity, and cost — the trade-off Yuequan claims its bionic structure solves.

The signal: The industry is shifting from lab demos to mass production. Research firm GGII expects China's dexterous-hand sales to top 70,000 units in 2026, and companies with original technology and full in-house development stand to lead the next phase.

Read more: 36Kr

Image credit: Nicodemus♐

More top stories